MNDA blocking peptide product blog
Tags: Blocking Peptide; MNDA; MNDA blocking peptide;
The MNDA mnda (Catalog #MBS9218253) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The MNDA mnda product has the following accession number(s) (GI #730038) (NCBI Accession #P41218.1) (Uniprot Accession #P41218). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
May act as a transcriptional activator/repressor in the myeloid lineage. Plays a role in the granulocyte/monocyte cell- specific response to interferon. Stimulates the DNA binding of the transcriptional repressor protein YY1.
Cellular Location: Nucleus. Cytoplasm. Note: Uniformly distributed throughout the interphase cell nucleus. Associates with chromatin. Tissue Location: Expressed constitutively in cells of the myeloid lineage. Found in promyelocyte stage cells as well as in all other stage cells including peripheral blood monocytes and granulocytes. Also appear in myeloblast cells in some cases of acute myeloid Leukemia. Atherosclerosis, Breast Neoplasms, Cardiovascular Diseases, Disease Models, Animal, Hematologic Diseases, Inflammation, Kidney Diseases, Necrosis, Neoplasms, Experimental, Weight Loss are some of the diseases may be linked to MNDA Antibody (N-term) Blocking peptide. Blood, Bone, Bone Marrow, Brain, Eye, Kidney, Lung, Spleen, Vascular tissues are correlated with this protein.